// App-Quantinova.ai

L03 : A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

Researchers

Presenter

  • Paul Emery

Principal Investigators

  • Jay Tuttle

  • Edit Drescher

  • Jesus Abraham Simón-Campos

  • Maria Greenwald

  • Alan Kivitz

  • Hyungmin Rha

  • Pia Yachi

  • Christina Kiley

  • Ajay Nirula

Medical Centers

  • Eli Lilly and Company, Indianapolis, IN

  • Csolnoky Ferenc Hospital, Veszprem, Hungary

  • Köhler & Milstein Research/Hospital Agustín O'Horán, Merida, Yucatan, Mexico

  • University of Leeds, Leeds, United Kingdom

  • Desert Medical Advances, Palm Desert, CA

  • Altoona Center for Clinical Research, Duncansville, PA

  • Eli Lilly, San Diego, CA

Locations

  • United States

  • Hungary

  • Mexico

  • United Kingdom

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT04634253

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved